Charlotte's Web Welcomes New CMS Guidance on Full-Spectrum Hemp Products

The botanical wellness company applauds the Centers for Medicare & Medicaid Services for expanding access to eligible hemp-derived CBD products.

Mar. 21, 2026 at 3:05am

Got story updates? Submit your updates here. ›

Charlotte's Web Holdings, Inc., a leading producer of CBD hemp extract wellness products, has expressed gratitude to the Centers for Medicare & Medicaid Services (CMS) for issuing new guidance that advances structured access to eligible full-spectrum hemp products through current CMS Innovation Center models. The CMS's Substance Access Beneficiary Engagement Incentive (BEI) program defines eligible hemp products as those containing up to 3 mg per serving of tetrahydrocannabinols, accommodating non-intoxicating full-spectrum hemp-derived CBD products.

Why it matters

This forward-looking framework from CMS supports patient-provider discussions around eligible hemp products, reinforcing science-driven policymaking that prioritizes consumer safety and product quality. The move aligns with Charlotte's Web's mission to advance safe, high-quality, science-backed hemp options for consumers and the company's commitment to championing policy solutions that uphold safety, transparency, and the availability of trusted full-spectrum hemp products.

The details

Under the BEI program, CMS has defined eligible hemp products to include orally administered products containing up to 3 mg per serving of tetrahydrocannabinols, a threshold that accommodates non-intoxicating full-spectrum hemp-derived CBD products. This guidance allows for responsible, evidence-based hemp wellness conversations in clinical settings and supports patient access to these products.

  • On March 20, 2026, Charlotte's Web Holdings, Inc. issued a press release welcoming the new CMS guidance.

The players

Charlotte's Web Holdings, Inc.

A botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, headquartered in Louisville, Colorado.

Centers for Medicare & Medicaid Services (CMS)

The federal agency that administers the Medicare program and works in partnership with state governments to administer Medicaid, the Children's Health Insurance Program (CHIP), and health insurance portability standards.

Bill Morachnick

The CEO of Charlotte's Web Holdings, Inc.

Got photos? Submit your photos here. ›

What they’re saying

“We are grateful for CMS's thoughtful approach in expanding access and creating space for responsible, evidence‑based hemp wellness conversations in clinical settings. This program aligns with our mission to advance safe, high‑quality, science‑backed hemp options for consumers, and we remain committed to supporting sensible legislation that protects patients and strengthens the integrity of our industry.”

— Bill Morachnick, CEO of Charlotte's Web

The takeaway

This CMS guidance represents a significant step forward in expanding patient access to safe, high-quality, science-backed hemp-derived CBD products, aligning with Charlotte's Web's mission to champion responsible, evidence-based hemp wellness solutions that prioritize consumer safety and product quality.